Empire Company Limited
Empire Company Limited (EMLAF) Stock Competitors & Peer Comparison
See (EMLAF) competitors and their performances in Stock Market.
Peer Comparison Table: Grocery Stores Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EMLAF | $36.20 | +1.03% | 8.3B | 75.42 | $0.48 | +1.71% |
| LBLCF | $46.54 | +1.04% | 54.5B | 30.62 | $1.52 | +0.88% |
| ADRNY | $48.27 | +1.28% | 43B | 16.70 | $2.89 | +2.81% |
| TSCDY | $19.50 | +2.20% | 42.3B | 21.67 | $0.90 | +2.84% |
| AHODF | $47.75 | +2.25% | 42.2B | 16.52 | $2.89 | +2.81% |
| TSCDF | $6.34 | +1.77% | 40.3B | 21.13 | $0.30 | +2.98% |
| SVNDY | $13.68 | -0.87% | 32.6B | 22.80 | $0.60 | +1.12% |
| SVNDF | $12.78 | +0.00% | 30.4B | 21.30 | $0.60 | +2.33% |
| WOLWF | $22.67 | +0.00% | 27.7B | 41.22 | $0.55 | +2.70% |
| WNGRF | $70.69 | +0.00% | 27.1B | 37.40 | $1.89 | +1.23% |
Stock Comparison
EMLAF vs LBLCF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, LBLCF has a market cap of 54.5B. Regarding current trading prices, EMLAF is priced at $36.20, while LBLCF trades at $46.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas LBLCF's P/E ratio is 30.62. In terms of profitability, EMLAF's ROE is +0.02%, compared to LBLCF's ROE of +0.24%. Regarding short-term risk, EMLAF is less volatile compared to LBLCF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check LBLCF's competition here
EMLAF vs ADRNY Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, ADRNY has a market cap of 43B. Regarding current trading prices, EMLAF is priced at $36.20, while ADRNY trades at $48.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas ADRNY's P/E ratio is 16.70. In terms of profitability, EMLAF's ROE is +0.02%, compared to ADRNY's ROE of +0.16%. Regarding short-term risk, EMLAF is less volatile compared to ADRNY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check ADRNY's competition here
EMLAF vs TSCDY Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, TSCDY has a market cap of 42.3B. Regarding current trading prices, EMLAF is priced at $36.20, while TSCDY trades at $19.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas TSCDY's P/E ratio is 21.67. In terms of profitability, EMLAF's ROE is +0.02%, compared to TSCDY's ROE of +0.14%. Regarding short-term risk, EMLAF is less volatile compared to TSCDY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check TSCDY's competition here
EMLAF vs AHODF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, AHODF has a market cap of 42.2B. Regarding current trading prices, EMLAF is priced at $36.20, while AHODF trades at $47.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas AHODF's P/E ratio is 16.52. In terms of profitability, EMLAF's ROE is +0.02%, compared to AHODF's ROE of +0.16%. Regarding short-term risk, EMLAF is less volatile compared to AHODF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check AHODF's competition here
EMLAF vs TSCDF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, TSCDF has a market cap of 40.3B. Regarding current trading prices, EMLAF is priced at $36.20, while TSCDF trades at $6.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas TSCDF's P/E ratio is 21.13. In terms of profitability, EMLAF's ROE is +0.02%, compared to TSCDF's ROE of +0.14%. Regarding short-term risk, EMLAF is less volatile compared to TSCDF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check TSCDF's competition here
EMLAF vs SVNDY Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, SVNDY has a market cap of 32.6B. Regarding current trading prices, EMLAF is priced at $36.20, while SVNDY trades at $13.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas SVNDY's P/E ratio is 22.80. In terms of profitability, EMLAF's ROE is +0.02%, compared to SVNDY's ROE of +0.08%. Regarding short-term risk, EMLAF is less volatile compared to SVNDY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check SVNDY's competition here
EMLAF vs SVNDF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, SVNDF has a market cap of 30.4B. Regarding current trading prices, EMLAF is priced at $36.20, while SVNDF trades at $12.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas SVNDF's P/E ratio is 21.30. In terms of profitability, EMLAF's ROE is +0.02%, compared to SVNDF's ROE of +0.08%. Regarding short-term risk, EMLAF is less volatile compared to SVNDF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check SVNDF's competition here
EMLAF vs WOLWF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, WOLWF has a market cap of 27.7B. Regarding current trading prices, EMLAF is priced at $36.20, while WOLWF trades at $22.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas WOLWF's P/E ratio is 41.22. In terms of profitability, EMLAF's ROE is +0.02%, compared to WOLWF's ROE of +0.13%. Regarding short-term risk, EMLAF and WOLWF have similar daily volatility (0.00).Check WOLWF's competition here
EMLAF vs WNGRF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, WNGRF has a market cap of 27.1B. Regarding current trading prices, EMLAF is priced at $36.20, while WNGRF trades at $70.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas WNGRF's P/E ratio is 37.40. In terms of profitability, EMLAF's ROE is +0.02%, compared to WNGRF's ROE of +0.20%. Regarding short-term risk, EMLAF and WNGRF have similar daily volatility (0.00).Check WNGRF's competition here
EMLAF vs CLEGF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, CLEGF has a market cap of 20.1B. Regarding current trading prices, EMLAF is priced at $36.20, while CLEGF trades at $14.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas CLEGF's P/E ratio is 28.23. In terms of profitability, EMLAF's ROE is +0.02%, compared to CLEGF's ROE of +0.26%. Regarding short-term risk, EMLAF is less volatile compared to CLEGF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check CLEGF's competition here
EMLAF vs KKOYY Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, KKOYY has a market cap of 17.7B. Regarding current trading prices, EMLAF is priced at $36.20, while KKOYY trades at $11.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas KKOYY's P/E ratio is 18.81. In terms of profitability, EMLAF's ROE is +0.02%, compared to KKOYY's ROE of +0.15%. Regarding short-term risk, EMLAF is less volatile compared to KKOYY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check KKOYY's competition here
EMLAF vs MTRAF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, MTRAF has a market cap of 14.4B. Regarding current trading prices, EMLAF is priced at $36.20, while MTRAF trades at $67.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas MTRAF's P/E ratio is 20.81. In terms of profitability, EMLAF's ROE is +0.02%, compared to MTRAF's ROE of +0.14%. Regarding short-term risk, EMLAF is less volatile compared to MTRAF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check MTRAF's competition here
EMLAF vs CRRFY Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, CRRFY has a market cap of 13.3B. Regarding current trading prices, EMLAF is priced at $36.20, while CRRFY trades at $3.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas CRRFY's P/E ratio is 11.45. In terms of profitability, EMLAF's ROE is +0.02%, compared to CRRFY's ROE of +0.03%. Regarding short-term risk, EMLAF is less volatile compared to CRRFY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check CRRFY's competition here
EMLAF vs CRERF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, CRERF has a market cap of 13B. Regarding current trading prices, EMLAF is priced at $36.20, while CRERF trades at $18.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas CRERF's P/E ratio is 11.22. In terms of profitability, EMLAF's ROE is +0.02%, compared to CRERF's ROE of +0.03%. Regarding short-term risk, EMLAF and CRERF have similar daily volatility (0.00).Check CRERF's competition here
EMLAF vs CVPBF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, CVPBF has a market cap of 12.1B. Regarding current trading prices, EMLAF is priced at $36.20, while CVPBF trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas CVPBF's P/E ratio is 15.11. In terms of profitability, EMLAF's ROE is +0.02%, compared to CVPBF's ROE of +0.22%. Regarding short-term risk, EMLAF and CVPBF have similar daily volatility (0.00).Check CVPBF's competition here
EMLAF vs CPPCY Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, CPPCY has a market cap of 12B. Regarding current trading prices, EMLAF is priced at $36.20, while CPPCY trades at $13.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas CPPCY's P/E ratio is 13.79. In terms of profitability, EMLAF's ROE is +0.02%, compared to CPPCY's ROE of +0.21%. Regarding short-term risk, EMLAF and CPPCY have similar daily volatility (0.00).Check CPPCY's competition here
EMLAF vs CVPUF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, CVPUF has a market cap of 11.6B. Regarding current trading prices, EMLAF is priced at $36.20, while CVPUF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas CVPUF's P/E ratio is 13.00. In terms of profitability, EMLAF's ROE is +0.02%, compared to CVPUF's ROE of +0.22%. Regarding short-term risk, EMLAF and CVPUF have similar daily volatility (0.00).Check CVPUF's competition here
EMLAF vs JSAIY Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, JSAIY has a market cap of 10.3B. Regarding current trading prices, EMLAF is priced at $36.20, while JSAIY trades at $18.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas JSAIY's P/E ratio is 19.04. In terms of profitability, EMLAF's ROE is +0.02%, compared to JSAIY's ROE of +0.05%. Regarding short-term risk, EMLAF is less volatile compared to JSAIY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check JSAIY's competition here
EMLAF vs JSNSF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, JSNSF has a market cap of 10.1B. Regarding current trading prices, EMLAF is priced at $36.20, while JSNSF trades at $4.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas JSNSF's P/E ratio is 18.20. In terms of profitability, EMLAF's ROE is +0.02%, compared to JSNSF's ROE of +0.05%. Regarding short-term risk, EMLAF and JSNSF have similar daily volatility (0.00).Check JSNSF's competition here
EMLAF vs DNOPY Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, DNOPY has a market cap of 8.9B. Regarding current trading prices, EMLAF is priced at $36.20, while DNOPY trades at $9.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas DNOPY's P/E ratio is 21.05. In terms of profitability, EMLAF's ROE is +0.02%, compared to DNOPY's ROE of +0.19%. Regarding short-term risk, EMLAF is less volatile compared to DNOPY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check DNOPY's competition here
EMLAF vs KKOYF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, KKOYF has a market cap of 8.8B. Regarding current trading prices, EMLAF is priced at $36.20, while KKOYF trades at $22.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas KKOYF's P/E ratio is 20.56. In terms of profitability, EMLAF's ROE is +0.02%, compared to KKOYF's ROE of +0.15%. Regarding short-term risk, EMLAF and KKOYF have similar daily volatility (0.00).Check KKOYF's competition here
EMLAF vs BMBRF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, BMBRF has a market cap of 6.8B. Regarding current trading prices, EMLAF is priced at $36.20, while BMBRF trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas BMBRF's P/E ratio is 16.91. In terms of profitability, EMLAF's ROE is +0.02%, compared to BMBRF's ROE of +0.13%. Regarding short-term risk, EMLAF is less volatile compared to BMBRF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check BMBRF's competition here
EMLAF vs DFILF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, DFILF has a market cap of 6.1B. Regarding current trading prices, EMLAF is priced at $36.20, while DFILF trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas DFILF's P/E ratio is 26.47. In terms of profitability, EMLAF's ROE is +0.02%, compared to DFILF's ROE of +0.52%. Regarding short-term risk, EMLAF is less volatile compared to DFILF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check DFILF's competition here
EMLAF vs AXFOY Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, AXFOY has a market cap of 5.9B. Regarding current trading prices, EMLAF is priced at $36.20, while AXFOY trades at $27.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas AXFOY's P/E ratio is 26.71. In terms of profitability, EMLAF's ROE is +0.02%, compared to AXFOY's ROE of +0.35%. Regarding short-term risk, EMLAF and AXFOY have similar daily volatility (0.00).Check AXFOY's competition here
EMLAF vs DFIHY Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, DFIHY has a market cap of 5.8B. Regarding current trading prices, EMLAF is priced at $36.20, while DFIHY trades at $21.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas DFIHY's P/E ratio is -15.36. In terms of profitability, EMLAF's ROE is +0.02%, compared to DFIHY's ROE of +0.52%. Regarding short-term risk, EMLAF is less volatile compared to DFIHY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check DFIHY's competition here
EMLAF vs GCHEF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, GCHEF has a market cap of 5.8B. Regarding current trading prices, EMLAF is priced at $36.20, while GCHEF trades at $6.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas GCHEF's P/E ratio is 16.30. In terms of profitability, EMLAF's ROE is +0.02%, compared to GCHEF's ROE of +0.13%. Regarding short-term risk, EMLAF and GCHEF have similar daily volatility (0.00).Check GCHEF's competition here
EMLAF vs KOBNF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, KOBNF has a market cap of 5.3B. Regarding current trading prices, EMLAF is priced at $36.20, while KOBNF trades at $24.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas KOBNF's P/E ratio is 26.48. In terms of profitability, EMLAF's ROE is +0.02%, compared to KOBNF's ROE of +0.18%. Regarding short-term risk, EMLAF and KOBNF have similar daily volatility (0.00).Check KOBNF's competition here
EMLAF vs CUYTF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, CUYTF has a market cap of 5.3B. Regarding current trading prices, EMLAF is priced at $36.20, while CUYTF trades at $44.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas CUYTF's P/E ratio is 14.65. In terms of profitability, EMLAF's ROE is +0.02%, compared to CUYTF's ROE of +0.09%. Regarding short-term risk, EMLAF and CUYTF have similar daily volatility (0.00).Check CUYTF's competition here
EMLAF vs AXFOF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, AXFOF has a market cap of 5.2B. Regarding current trading prices, EMLAF is priced at $36.20, while AXFOF trades at $24.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas AXFOF's P/E ratio is 23.34. In terms of profitability, EMLAF's ROE is +0.02%, compared to AXFOF's ROE of +0.36%. Regarding short-term risk, EMLAF and AXFOF have similar daily volatility (0.00).Check AXFOF's competition here
EMLAF vs CUYTY Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, CUYTY has a market cap of 4.5B. Regarding current trading prices, EMLAF is priced at $36.20, while CUYTY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas CUYTY's P/E ratio is 13.53. In terms of profitability, EMLAF's ROE is +0.02%, compared to CUYTY's ROE of +0.09%. Regarding short-term risk, EMLAF and CUYTY have similar daily volatility (0.00).Check CUYTY's competition here
EMLAF vs SHUFF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, SHUFF has a market cap of 3.4B. Regarding current trading prices, EMLAF is priced at $36.20, while SHUFF trades at $12.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas SHUFF's P/E ratio is 16.04. In terms of profitability, EMLAF's ROE is +0.02%, compared to SHUFF's ROE of +0.17%. Regarding short-term risk, EMLAF is less volatile compared to SHUFF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check SHUFF's competition here
EMLAF vs GGGSF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, GGGSF has a market cap of 2.2B. Regarding current trading prices, EMLAF is priced at $36.20, while GGGSF trades at $21.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas GGGSF's P/E ratio is 13.77. In terms of profitability, EMLAF's ROE is +0.02%, compared to GGGSF's ROE of +0.20%. Regarding short-term risk, EMLAF is less volatile compared to GGGSF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check GGGSF's competition here
EMLAF vs OCDDY Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, OCDDY has a market cap of 2B. Regarding current trading prices, EMLAF is priced at $36.20, while OCDDY trades at $4.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas OCDDY's P/E ratio is -3.84. In terms of profitability, EMLAF's ROE is +0.02%, compared to OCDDY's ROE of +0.06%. Regarding short-term risk, EMLAF is less volatile compared to OCDDY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check OCDDY's competition here
EMLAF vs GGGSY Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, GGGSY has a market cap of 2B. Regarding current trading prices, EMLAF is priced at $36.20, while GGGSY trades at $6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas GGGSY's P/E ratio is 12.26. In terms of profitability, EMLAF's ROE is +0.02%, compared to GGGSY's ROE of +0.20%. Regarding short-term risk, EMLAF is less volatile compared to GGGSY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check GGGSY's competition here
EMLAF vs OCDGF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, OCDGF has a market cap of 2B. Regarding current trading prices, EMLAF is priced at $36.20, while OCDGF trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas OCDGF's P/E ratio is -3.75. In terms of profitability, EMLAF's ROE is +0.02%, compared to OCDGF's ROE of +0.24%. Regarding short-term risk, EMLAF is less volatile compared to OCDGF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check OCDGF's competition here
EMLAF vs NNWWF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, NNWWF has a market cap of 1.9B. Regarding current trading prices, EMLAF is priced at $36.20, while NNWWF trades at $39.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas NNWWF's P/E ratio is 18.40. In terms of profitability, EMLAF's ROE is +0.02%, compared to NNWWF's ROE of +0.18%. Regarding short-term risk, EMLAF and NNWWF have similar daily volatility (0.00).Check NNWWF's competition here
EMLAF vs CGUSY Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, CGUSY has a market cap of 1.7B. Regarding current trading prices, EMLAF is priced at $36.20, while CGUSY trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas CGUSY's P/E ratio is -0.00. In terms of profitability, EMLAF's ROE is +0.02%, compared to CGUSY's ROE of -33.50%. Regarding short-term risk, EMLAF and CGUSY have similar daily volatility (0.00).Check CGUSY's competition here
EMLAF vs RLEVF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, RLEVF has a market cap of 1B. Regarding current trading prices, EMLAF is priced at $36.20, while RLEVF trades at $74.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas RLEVF's P/E ratio is 15.38. In terms of profitability, EMLAF's ROE is +0.02%, compared to RLEVF's ROE of +0.39%. Regarding short-term risk, EMLAF is less volatile compared to RLEVF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check RLEVF's competition here
EMLAF vs EUSHY Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, EUSHY has a market cap of 267.9M. Regarding current trading prices, EMLAF is priced at $36.20, while EUSHY trades at $1.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas EUSHY's P/E ratio is -38.50. In terms of profitability, EMLAF's ROE is +0.02%, compared to EUSHY's ROE of -0.04%. Regarding short-term risk, EMLAF is less volatile compared to EUSHY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check EUSHY's competition here
EMLAF vs EUSHF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, EUSHF has a market cap of 238M. Regarding current trading prices, EMLAF is priced at $36.20, while EUSHF trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas EUSHF's P/E ratio is -10.69. In terms of profitability, EMLAF's ROE is +0.02%, compared to EUSHF's ROE of -0.04%. Regarding short-term risk, EMLAF and EUSHF have similar daily volatility (0.00).Check EUSHF's competition here
EMLAF vs CGUIF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, CGUIF has a market cap of 91M. Regarding current trading prices, EMLAF is priced at $36.20, while CGUIF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas CGUIF's P/E ratio is -0.03. In terms of profitability, EMLAF's ROE is +0.02%, compared to CGUIF's ROE of -0.50%. Regarding short-term risk, EMLAF and CGUIF have similar daily volatility (0.00).Check CGUIF's competition here
EMLAF vs FLOCF Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, FLOCF has a market cap of 6.2M. Regarding current trading prices, EMLAF is priced at $36.20, while FLOCF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas FLOCF's P/E ratio is -0.25. In terms of profitability, EMLAF's ROE is +0.02%, compared to FLOCF's ROE of +2.82%. Regarding short-term risk, EMLAF and FLOCF have similar daily volatility (0.00).Check FLOCF's competition here
EMLAF vs HCMC Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, HCMC has a market cap of 4.8M. Regarding current trading prices, EMLAF is priced at $36.20, while HCMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas HCMC's P/E ratio is N/A. In terms of profitability, EMLAF's ROE is +0.02%, compared to HCMC's ROE of +2.93%. Regarding short-term risk, EMLAF is less volatile compared to HCMC. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check HCMC's competition here
EMLAF vs MTVX Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, MTVX has a market cap of 822.8K. Regarding current trading prices, EMLAF is priced at $36.20, while MTVX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas MTVX's P/E ratio is N/A. In terms of profitability, EMLAF's ROE is +0.02%, compared to MTVX's ROE of +0.39%. Regarding short-term risk, EMLAF is less volatile compared to MTVX. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check MTVX's competition here
EMLAF vs IFMK Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, IFMK has a market cap of 48.1K. Regarding current trading prices, EMLAF is priced at $36.20, while IFMK trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas IFMK's P/E ratio is -0.01. In terms of profitability, EMLAF's ROE is +0.02%, compared to IFMK's ROE of +4.63%. Regarding short-term risk, EMLAF is less volatile compared to IFMK. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check IFMK's competition here
EMLAF vs OMHI Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, OMHI has a market cap of 20.9K. Regarding current trading prices, EMLAF is priced at $36.20, while OMHI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas OMHI's P/E ratio is N/A. In terms of profitability, EMLAF's ROE is +0.02%, compared to OMHI's ROE of +0.15%. Regarding short-term risk, EMLAF is less volatile compared to OMHI. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check OMHI's competition here
EMLAF vs HWIN Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, HWIN has a market cap of 3.6K. Regarding current trading prices, EMLAF is priced at $36.20, while HWIN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas HWIN's P/E ratio is N/A. In terms of profitability, EMLAF's ROE is +0.02%, compared to HWIN's ROE of -0.37%. Regarding short-term risk, EMLAF is less volatile compared to HWIN. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check HWIN's competition here
EMLAF vs MFLTY Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, MFLTY has a market cap of 2.3K. Regarding current trading prices, EMLAF is priced at $36.20, while MFLTY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas MFLTY's P/E ratio is N/A. In terms of profitability, EMLAF's ROE is +0.02%, compared to MFLTY's ROE of +1.75%. Regarding short-term risk, EMLAF is less volatile compared to MFLTY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check MFLTY's competition here
EMLAF vs QKLS Comparison April 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.3B. In comparison, QKLS has a market cap of 152. Regarding current trading prices, EMLAF is priced at $36.20, while QKLS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 75.42, whereas QKLS's P/E ratio is N/A. In terms of profitability, EMLAF's ROE is +0.02%, compared to QKLS's ROE of -2.85%. Regarding short-term risk, EMLAF and QKLS have similar daily volatility (0.00).Check QKLS's competition here